Selecta Biosciences, Inc. SELB
0.88 0.00 (+0.00%)
At closeNov 13, 2023, 4:00 PM EST
0.81 Day range 0.9399
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 2.80 +217.7% upside
Now 0.8812
- Target (low)
- 1.00
- Target (mean)
- 2.80
- Target (high)
- 5.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
- Strong buy2
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 6
- 2 months ago 6
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.06 | -0.10 – 0.04 | -0.05 | -20.0% | 11.02M | -56.3% | 6 |
| Next quarter | -0.07 | -0.12 – -0.03 | 0.04 | -275.0% | 6.84M | -59.3% | 6 |
| Current year | -0.35 | -0.41 – -0.28 | 0.10 | -450.0% | 29.03M | -73.8% | 6 |
| Next year | -0.15 | -0.48 – 0.15 | -0.35 | +57.1% | 41.18M | +41.9% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 17, 2023 | Mizuho | Maintained | Buy | Buy |
| Aug 17, 2023 | SVB Leerink | Downgrade | Outperform | Market Perform |
| Aug 17, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 17, 2023 | Needham | Maintained | Buy | Buy |
| May 7, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 4, 2023 | Needham | Reiterated | — | Buy |
| Apr 12, 2023 | Needham | Reiterated | — | Buy |
| Mar 21, 2023 | Mizuho | Maintained | — | Buy |
| Mar 21, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 20, 2023 | Needham | Reiterated | — | Buy |
| Mar 2, 2023 | Needham | Reiterated | — | Buy |
| Jan 30, 2023 | Canaccord Genuity | Maintained | — | Buy |
| Jun 20, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 13, 2022 | Needham | Maintained | — | Buy |
| Jun 5, 2022 | SVB Leerink | Initiated | — | Outperform |
| May 5, 2022 | Needham | Maintained | — | Buy |
| Oct 31, 2021 | Needham | Maintained | — | Buy |
| Jun 14, 2021 | BTIG | Initiated | — | Buy |
| Mar 11, 2021 | William Blair | Upgrade | Market Perform | Outperform |
| Jan 25, 2021 | Mizuho | Upgrade | Neutral | Buy |
| Oct 4, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 30, 2020 | William Blair | Downgrade | Outperform | Market Perform |
| Sep 30, 2020 | Mizuho | Downgrade | Buy | Neutral |
| Jun 11, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 18, 2020 | Mizuho | Maintained | — | Buy |
| Feb 17, 2020 | Mizuho | Maintained | — | Buy |
| Jan 28, 2020 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jan 20, 2020 | William Blair | Initiated | — | Outperform |
| Jun 26, 2018 | Janney Montgomery Scott | Initiated | — | Buy |
| Feb 26, 2018 | Mizuho | Initiated | — | Buy |